Short Term Rating on Stryker Corporation (SYK)

Stryker Corporation (SYK) : The consensus on Stryker Corporation (SYK) based on 24 analyst recommendation on the company stock is 1.9, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 14 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 6 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 2 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.

Stryker Corporation (SYK) : Average target price received by Stryker Corporation (SYK) is $119.28 with an expected standard deviation of $10.72. The most aggressive target on the stock is $134, whereas the most downbeat target is $88. 18 financial analysts are currently covering the stock.

For the current week, the company shares have a recommendation consensus of Buy.


Stryker Corporation (NYSE:SYK): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $122.93 and $122.18 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $123.21. The buying momentum continued till the end and the stock did not give up its gains. It closed at $122.82, notching a gain of 0.14% for the day. The total traded volume was 1,233,434 . The stock had closed at $122.65 on the previous day.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.